• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p90 核糖体 S6 激酶 2 的活性 N 端激酶结构域的结构多样性。

Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.

机构信息

Department of Cellular and Molecular Biology, The Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America.

出版信息

PLoS One. 2009 Nov 30;4(11):e8044. doi: 10.1371/journal.pone.0008044.

DOI:10.1371/journal.pone.0008044
PMID:19956600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2779450/
Abstract

The p90 ribosomal protein kinase 2 (RSK2) is a highly expressed Ser/Thr kinase activated by growth factors and is involved in cancer cell proliferation and tumor promoter-induced cell transformation. RSK2 possesses two non-identical kinase domains, and the structure of its N-terminal domain (NTD), which is responsible for phosphorylation of a variety of substrates, is unknown. The crystal structure of the NTD RSK2 was determined at 1.8 A resolution in complex with AMP-PNP. The N-terminal kinase domain adopted a unique active conformation showing a significant structural diversity of the kinase domain compared to other kinases. The NTD RSK2 possesses a three-stranded betaB-sheet inserted in the N-terminal lobe, resulting in displacement of the alphaC-helix and disruption of the Lys-Glu interaction, classifying the kinase conformation as inactive. The purified protein was phosphorylated at Ser227 in the T-activation loop and exhibited in vitro kinase activity. A key characteristic is the appearance of a new contact between Lys216 (betaB-sheet) and the beta-phosphate of AMP-PNP. Mutation of this lysine to alanine impaired both NTDs in vitro and full length RSK2 ex vivo activity, emphasizing the importance of this interaction. Even though the N-terminal lobe undergoes structural re-arrangement, it possesses an intact hydrophobic groove formed between the alphaC-helix, the beta4-strand, and the betaB-sheet junction, which is occupied by the N-terminal tail. The presence of a unique betaB-sheet insert in the N-lobe suggests a different type of activation mechanism for RSK2.

摘要

p90 核糖体 S6 蛋白激酶 2(RSK2)是一种高度表达的 Ser/Thr 激酶,可被生长因子激活,参与癌细胞增殖和肿瘤促进剂诱导的细胞转化。RSK2 具有两个非同源的激酶结构域,其负责磷酸化多种底物的 N 端结构域(NTD)的结构未知。与 AMP-PNP 复合物的 1.8Å 分辨率的 NTD RSK2 的晶体结构已被确定。N 端激酶结构域采用独特的活性构象,与其他激酶相比,激酶结构域具有显著的结构多样性。NTD RSK2 具有插入在 N 端结构域中的三股βB-折叠,导致αC-螺旋位移和 Lys-Glu 相互作用的破坏,将激酶构象分类为非活性。纯化的蛋白在 T 激活环的 Ser227 处被磷酸化,并表现出体外激酶活性。一个关键特征是 Lys216(βB-折叠)和 AMP-PNP 的β-磷酸之间出现新的接触。该赖氨酸突变为丙氨酸会损害 NTD 在体外和全长 RSK2 体外的活性,强调了这种相互作用的重要性。尽管 N 端结构域发生了结构重排,但它具有一个完整的疏水性沟,由αC-螺旋、β4 链和βB-折叠交界处形成,该沟被 N 端尾巴占据。N 端结构域中独特的βB-折叠插入的存在表明 RSK2 具有不同类型的激活机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/23018c97d357/pone.0008044.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/0d9c55f3f94d/pone.0008044.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/5ca23fa248e7/pone.0008044.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/f777cadf514e/pone.0008044.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/77fa83c4ff3f/pone.0008044.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/094eba4f6bca/pone.0008044.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/d71eb93da88f/pone.0008044.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/af2576c84896/pone.0008044.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/90654eebf808/pone.0008044.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/23018c97d357/pone.0008044.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/0d9c55f3f94d/pone.0008044.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/5ca23fa248e7/pone.0008044.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/f777cadf514e/pone.0008044.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/77fa83c4ff3f/pone.0008044.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/094eba4f6bca/pone.0008044.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/d71eb93da88f/pone.0008044.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/af2576c84896/pone.0008044.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/90654eebf808/pone.0008044.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7145/2779450/23018c97d357/pone.0008044.g009.jpg

相似文献

1
Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.p90 核糖体 S6 激酶 2 的活性 N 端激酶结构域的结构多样性。
PLoS One. 2009 Nov 30;4(11):e8044. doi: 10.1371/journal.pone.0008044.
2
Structural basis for activation of the autoinhibitory C-terminal kinase domain of p90 RSK2.p90核糖体S6激酶2(p90 RSK2)自抑制性C末端激酶结构域激活的结构基础
Nat Struct Mol Biol. 2008 Jan;15(1):112-3. doi: 10.1038/nsmb1347. Epub 2007 Dec 16.
3
p90 ribosomal S6 kinase 2 is associated with and dephosphorylated by protein phosphatase 2Cdelta.p90核糖体S6激酶2与蛋白磷酸酶2Cδ相关并被其去磷酸化。
Biochem J. 2004 Sep 1;382(Pt 2):425-31. doi: 10.1042/BJ20040948.
4
Characterization of the p90 ribosomal S6 kinase 2 carboxyl-terminal domain as a protein kinase.将p90核糖体S6激酶2羧基末端结构域鉴定为一种蛋白激酶。
J Biol Chem. 2002 Aug 2;277(31):27733-41. doi: 10.1074/jbc.M202663200. Epub 2002 May 16.
5
The structure of MSK1 reveals a novel autoinhibitory conformation for a dual kinase protein.MSK1的结构揭示了一种双激酶蛋白的新型自抑制构象。
Structure. 2004 Jun;12(6):1067-77. doi: 10.1016/j.str.2004.02.040.
6
Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.与三种不同配体结合的人源RSK1 N端激酶结构域的晶体结构:对RSK1特异性抑制剂设计的启示
Protein Sci. 2007 Dec;16(12):2626-35. doi: 10.1110/ps.073123707. Epub 2007 Oct 26.
7
A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1.蛋白激酶RSK2中一个受磷酸丝氨酸调节的对接位点,该位点招募并激活PDK1。
EMBO J. 2000 Jun 15;19(12):2924-34. doi: 10.1093/emboj/19.12.2924.
8
A regulatory mechanism for RSK2 NH(2)-terminal kinase activity.一种针对RSK2氨基末端激酶活性的调节机制。
Cancer Res. 2009 May 15;69(10):4398-406. doi: 10.1158/0008-5472.CAN-08-4959. Epub 2009 May 12.
9
Bacterial Expression, Purification and In Vitro Phosphorylation of Full-Length Ribosomal S6 Kinase 2 (RSK2).全长核糖体 S6 激酶 2(RSK2)的细菌表达、纯化和体外磷酸化。
PLoS One. 2016 Oct 12;11(10):e0164343. doi: 10.1371/journal.pone.0164343. eCollection 2016.
10
Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore.RSK2 N端激酶结构域的同源性模型、新型RSK2抑制剂的基于结构的鉴定及初步共同药效团
Bioorg Med Chem. 2006 Sep 1;14(17):6097-105. doi: 10.1016/j.bmc.2006.05.001. Epub 2006 May 24.

引用本文的文献

1
RiSKs in Computational Modeling of Isoform-Selective RSK Inhibitors.亚型选择性RSK抑制剂计算建模中的风险
J Chem Inf Model. 2025 Aug 25;65(16):8411-8425. doi: 10.1021/acs.jcim.5c00951. Epub 2025 Aug 12.
2
MSK-Mediated Phosphorylation of Histone H3 Ser28 Couples MAPK Signalling with Early Gene Induction and Cardiac Hypertrophy.MSK 介导的组蛋白 H3 Ser28 磷酸化将 MAPK 信号与早期基因诱导和心脏肥大偶联。
Cells. 2022 Feb 9;11(4):604. doi: 10.3390/cells11040604.
3
A non-catalytic herpesviral protein reconfigures ERK-RSK signaling by targeting kinase docking systems in the host.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Structural basis for activation of the autoinhibitory C-terminal kinase domain of p90 RSK2.p90核糖体S6激酶2(p90 RSK2)自抑制性C末端激酶结构域激活的结构基础
Nat Struct Mol Biol. 2008 Jan;15(1):112-3. doi: 10.1038/nsmb1347. Epub 2007 Dec 16.
3
Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.
一种非催化疱疹病毒蛋白通过靶向宿主中的激酶衔接系统来重新配置 ERK-RSK 信号通路。
Nat Commun. 2022 Jan 25;13(1):472. doi: 10.1038/s41467-022-28109-x.
4
RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study.海洋β-咔啉生物碱马尼胺 A 对 RSK1 和 RSK2 的抑制活性:生化、宫颈癌蛋白表达和计算研究。
Mar Drugs. 2021 Sep 7;19(9):506. doi: 10.3390/md19090506.
5
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.靶向 RSK4 的再利用 floxacins 可预防肺癌和膀胱癌的化疗耐药和转移。
Sci Transl Med. 2021 Jul 14;13(602). doi: 10.1126/scitranslmed.aba4627.
6
Activation of RSK by phosphomimetic substitution in the activation loop is prevented by structural constraints.在激活环中通过磷酸模拟取代激活 RSK 会受到结构限制。
Sci Rep. 2020 Jan 17;10(1):591. doi: 10.1038/s41598-019-56937-3.
7
Disordered Protein Kinase Regions in Regulation of Kinase Domain Cores.蛋白激酶结构域无序区对激酶结构域核心的调控
Trends Biochem Sci. 2019 Apr;44(4):300-311. doi: 10.1016/j.tibs.2018.12.002. Epub 2019 Jan 2.
8
Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2.熊果酸通过靶向RSK2抑制患者来源的胃肿瘤生长。
Oncotarget. 2018 Feb 6;9(76):34200-34212. doi: 10.18632/oncotarget.24409. eCollection 2018 Sep 28.
9
RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth.RSK2 磷酸化 T-bet 以抑制结肠癌转移和生长。
Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):12791-12796. doi: 10.1073/pnas.1710756114. Epub 2017 Nov 13.
10
Myricetin inhibits proliferation and induces apoptosis and cell cycle arrest in gastric cancer cells.杨梅素抑制胃癌细胞的增殖并诱导其凋亡及细胞周期停滞。
Mol Cell Biochem. 2015 Oct;408(1-2):163-70. doi: 10.1007/s11010-015-2492-1. Epub 2015 Jun 27.
与三种不同配体结合的人源RSK1 N端激酶结构域的晶体结构:对RSK1特异性抑制剂设计的启示
Protein Sci. 2007 Dec;16(12):2626-35. doi: 10.1110/ps.073123707. Epub 2007 Oct 26.
4
Crystal structure of the kinase domain of serum and glucocorticoid-regulated kinase 1 in complex with AMP PNP.血清和糖皮质激素调节激酶1激酶结构域与AMP PNP复合物的晶体结构
Protein Sci. 2007 Dec;16(12):2761-9. doi: 10.1110/ps.073161707. Epub 2007 Oct 26.
5
Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: structure of lck/imatinib complex.对蛋白激酶结构进行分类有助于利用配体选择性谱来预测非活性构象:Lck/伊马替尼复合物的结构
Proteins. 2008 Mar;70(4):1451-60. doi: 10.1002/prot.21633.
6
Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.核糖体S6激酶2是肿瘤启动子诱导细胞转化中的关键调节因子。
Cancer Res. 2007 Sep 1;67(17):8104-12. doi: 10.1158/0008-5472.CAN-06-4668.
7
Structural basis for the autoinhibition of focal adhesion kinase.粘着斑激酶自身抑制的结构基础。
Cell. 2007 Jun 15;129(6):1177-87. doi: 10.1016/j.cell.2007.05.041.
8
Mechanism for activation of the growth factor-activated AGC kinases by turn motif phosphorylation.通过转角基序磷酸化激活生长因子激活的AGC激酶的机制。
EMBO J. 2007 May 2;26(9):2251-61. doi: 10.1038/sj.emboj.7601682. Epub 2007 Apr 19.
9
The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module.AGC激酶功能分化的标志是其C末端尾巴,一个顺式作用调节模块。
Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1272-7. doi: 10.1073/pnas.0610251104. Epub 2007 Jan 16.
10
RSK2 mediates muscle cell differentiation through regulation of NFAT3.核糖体S6激酶2(RSK2)通过调节活化T细胞核因子3(NFAT3)介导肌肉细胞分化。
J Biol Chem. 2007 Mar 16;282(11):8380-92. doi: 10.1074/jbc.M611322200. Epub 2007 Jan 9.